Thymidylate synthase with a C-terminal deletion catalyzes partial reactions but is unable to catalyze thymidylate

C W Carreras1, S C Climie, D V Santi

  • 1Department of Pharmaceutical Chemistry, University of California, San Francisco 94143-0448.

Biochemistry
|July 7, 1992
PubMed

Insights

The Lactobacillus casei thymidylate synthase V316Am mutant, lacking a C-terminal valine, cannot form dTMP but retains partial catalytic activity. This indicates the mutation affects later steps in the reaction mechanism, not initial cofactor binding.

Area of Science:

  • Enzymology
  • Biochemistry
  • Molecular Biology

Background:

  • Lactobacillus casei thymidylate synthase (TS) is crucial for DNA synthesis.
  • Mutations can reveal insights into enzyme mechanisms and active site residues.

Purpose of the Study:

  • To investigate the catalytic mechanism of the V316Am mutant of Lactobacillus casei TS.
  • To determine the role of the C-terminal valine in TS catalysis and substrate binding.

Main Methods:

  • Enzyme kinetics assays were performed on the V316Am mutant.
  • Catalytic activity, inhibition patterns, and complex formation were analyzed.
  • Comparison with wild-type TS was conducted.

Main Results:

  • V316Am lacks dTMP formation activity but retains partial reactions: 5-hydrogen exchange and dehalogenation.
  • Similar kcat and Km values for partial reactions suggest intact substrate binding and covalent catalysis.
  • Competitive inhibition by dUMP, dTMP, and FdUMP indicates preserved nucleotide binding.
  • V316Am forms a covalent ternary complex, but with reduced cofactor affinity and stability.

Conclusions:

  • The C-terminal valine is not essential for substrate binding or initial covalent bond formation.
  • The V316Am mutation primarily affects steps subsequent to cofactor binding in the TS catalytic cycle.

Related Concept Videos

Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...